Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP+ randomized controlled trial

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

(2023) Aideen B. Daly et al.   NATURE MEDICINE

Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy

(2023) Georgia M. Davis et al.   DIABETES CARE

Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers

(2023) Johan Jendle et al.   DIABETES OBESITY & METABOLISM

Beneficial Effects of Control-IQ Automated Insulin Delivery in Basal-Bolus and Basal-Only Insulin Users With Type 2 Diabetes

(2023) Carol J. Levy et al.   Clinical Diabetes

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

(2022) Moshe Phillip et al.   ENDOCRINE REVIEWS

The experiences of insulin use among older people with Type 2 diabetes mellitus: A thematic synthesis

(2022) Chaya Langerman et al.   Primary Care Diabetes

13. Older Adults: Standards of Care in Diabetes—2023

(2022) Nuha A. ElSayed et al.   DIABETES CARE

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023

(2022) Nuha A. ElSayed et al.   DIABETES CARE

Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial

(2021) Charlotte K. Boughton et al.   NATURE MEDICINE

Fully closed-loop insulin delivery Improves glucose control of inpatients with type 2 diabetes receiving hemodialysis

(2019) Lia Bally et al.   KIDNEY INTERNATIONAL

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes

(2019) Sue A. Brown et al.   NEW ENGLAND JOURNAL OF MEDICINE

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

(2018) Eleni Bekiari et al.   BMJ-British Medical Journal

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

(2018) Eleni Bekiari et al.   BMJ-British Medical Journal

Closed-Loop Insulin for Glycemic Control in Noncritical Care

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Sustained Efficacy of Insulin Pump Therapy in Type 2 Diabetes: 9-Year Follow-up in a Cohort of 161 Patients: Table 1

(2016) Julia Morera et al.   DIABETES CARE

Sustained efficacy of insulin pump therapy compared with multiple daily injections in type 2 diabetes: 12-month data from the OpT2mise randomized trial

(2016) R. Aronson et al.   DIABETES OBESITY & METABOLISM

Hypoglycemia, frailty and dementia in older people with diabetes: Reciprocal relations and clinical implications

(2016) Ahmed H. Abdelhafiz et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial

(2014) Yves Reznik et al.   LANCET

Diabetes in Older Adults

(2012) M. S. Kirkman et al.   DIABETES CARE

Symptom Burden of Adults with Type 2 Diabetes Across the Disease Course: Diabetes & Aging Study

(2012) Rebecca L. Sudore et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Correlates of Quality of Life in Older Adults With Diabetes

(2011) Neda Laiteerapong et al.   DIABETES CARE